Page 153 - TD-3-4

Tumor Discovery Primarily enucleated RB patient’s analysis

12. Alsharif H, Helmi H, Maktabi A. Histopathological doi: 10.1200/JGO.17.00056
characteristics and classification for prognostic indicators. 23. Utomo PT, Respatika D, Ardianto B, et al. Lag time, high-risk
In: Manaa Alkatan H, editor. Retinoblastoma-Past, Present histopathological features, metastasis, and survival interrelation
and Future. London, UK: IntechOpen; 2019.
in retinoblastoma: A perspective from lower-middle income
doi: 10.5772/intechopen.89410 country. Int J Ophthalmol. 2022;15(12):1994-2000.
13. Mendoza PR, Specht CS, Hubbard GB, et al. Histopathologic doi: 10.18240/ijo.2022.12.15
grading of anaplasia in retinoblastoma. Am J Ophthalmol. 24. Tan RJ, Umerez DC, Alindayu JI, Conjares MJ, Go DA,
2015;159(4):764-776.
Paulino RG. Retinoblastoma in South Asia: A scoping
doi: 10.1016/j.ajo.2014.12.014 review. Asian Pac J Cancer Care. 2021;6(4):493-500.
14. Alkatan HM, Al Marek F, Elkhamary S. Demographics of doi: 10.31557/APJCC.2021.6.4.493
pediatric orbital lesions: A tertiary eye center experience in 25. Reddy SC, Anusya S. Clinical presentation of retinoblastoma
Saudi Arabia. J Epidemiol Glob Health. 2019;9(1):3-10.
in Malaysia: A review of 64 patients. Int J Ophthalmol.
doi: 10.2991/jegh.k.181224.001 2010;3(1):64-8.
15. Jain M, Rojanaporn D, Chawla B, Sundar G, Gopal L, Khetan V. doi: 10.3980/j.issn.2222-3959.2010.01.15.
Retinoblastoma in Asia. Eye (Lond). 2019;33(1):87-96.
26. Cruz-Gálvez CC, Ordaz-Favila JC, Villar-Calvo VM,
doi: 10.1038/s41433-018-0244-7 Cancino-Marentes ME, Bosch-Canto V. Retinoblastoma:
Review and new insights. Front Oncol. 2022 Nov 2;12:963780.
16. Kaliki S, Vempuluru VS, Mohamed A, et al. Retinoblastoma
in Asia: Clinical presentation and treatment outcomes doi: 10.3389/fonc.2022.963780
in 2112 patients from 33 countries. Ophthalmology. 27. Kashyap S, Sethi S, Meel R, et al. A histopathologic analysis
2024;131(4):468-477.
of eyes primarily enucleated for advanced intraocular
doi: 10.1016/j.ophtha.2023.10.015 retinoblastoma from a developing country. Arch Pathol Lab
Med. 2012;136(2):190-193.
17. Zhao J, Feng Z, Leung G, Gallie BL. Retinoblastoma survival
following primary enucleation by AJCC staging. Cancers doi: 10.5858/arpa.2010-0759-OA
(Basel). 2021;13(24):6240.
28. Gupta R, Vemuganti GK, Reddy VA, Honavar SG.
doi: 10.3390/cancers13246240 Histopathologic risk factors in retinoblastoma in India. Arch
Pathol Lab Med. 2009;133(8):1210-1214.
18. Roy SR, Nuruddin M, Asgar A. Scenario of retinoblastoma
among Bangladeshi children – a single center experience doi: 10.5858/133.8.1210
of 10 years. BOHR Int J Curr Res Optometry Ophthalmol. 29. Sari NM, Hadiputri R, Kuntorini MS, Agustina H,
2022;1(1):62-66.
Mardianty F. High-risk histopathologic features of
doi: 10.54646/bijcroo.017 retinoblastoma treated at a tertiary hospital in West Java,
Indonesia. Ocul Oncol Pathol. 2021;7(5):353-360.
19. Gupta N, Pandey A, Dimri K, Prinja S. Epidemiological
profile of retinoblastoma in North India: Implications for doi: 10.1159/000517100
primary care and family physicians. J Family Med Prim Care. 30. Kaliki S, Gupta S, Ramappa G, Mohamed A, Mishra DK. High-
2020;9(6):2843-2848.
risk retinoblastoma based on age at primary enucleation:
doi: 10.4103/jfmpc.jfmpc_265_20 A study of 616 eyes. Eye (Lond). 2020;34(8):1441-1448.
20. Ali MS, Sinha R, Bhaskar G, Kumari N, Sinha B. Demographic doi: 10.1038/s41433-019-0698-2
and clinical characteristics of retinoblastoma cases at a tertiary 31. Chévez-Barrios P, Eagle RC Jr., Krailo M, et al. Study of
care center in Eastern India. Cureus. 2024;16(7):e64659.
unilateral retinoblastoma with and without histopathologic
doi: 10.7759/cureus.64659 high-risk features and the role of adjuvant chemotherapy:
A children’s oncology group study. J Clin Oncol.
21. Fabian ID, Khetan V, Stacey AW, et al. Sex, gender, and
retinoblastoma: Analysis of 4351 patients from 153 2019;37(31):2883-2891.
countries. Eye (Lond). 2022;36(8):1571-1577. doi: 10.1200/JCO.18.01808
doi: 10.1038/s41433-021-01675-y 32. Kaliki S, Shields CL, Eagle RC Jr., Iram S, Shields JA. High-
risk intraocular retinoblastoma: Comparison between Asian
22. Lukamba RM, Yao JA, Kabesha TA, et al. Retinoblastoma
in Sub-Saharan Africa: Case studies of the republic of côte Indians and Americans from two major referral centers.
d’ivoire and the democratic republic of the Congo. J Glob Retina. 2018;38(10):2023-2029.
Oncol. 2018;4:1-8. doi: 10.1097/IAE.0000000000001816

Volume 3 Issue 4 (2024) 10 doi: 10.36922/td.4336